Abstract
This review focuses on the roles of flow cytometric immunophenotyping has in the differential diagnosis of plasma cell neoplasms and the post-therapy monitoring of minimal (measurable) residual disease. The need to integrate flow cytometry data with clinical, laboratory, radiographic, morphological, and molecular genetic findings is emphasized. The challenges of and strategies for evaluating plasma cells in the setting of targeted therapy are also highlighted. © 2019 International Clinical Cytometry Society.
Author supplied keywords
Cite
CITATION STYLE
Wang, H. W., & Lin, P. (2019, September 1). Flow Cytometric Immunophenotypic Analysis in the Diagnosis and Prognostication of Plasma Cell Neoplasms. Cytometry Part B - Clinical Cytometry. John Wiley and Sons Inc. https://doi.org/10.1002/cyto.b.21844
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.